ALVOGEN, PHARMA US, INC.

Lobbying client · New Jersey · filed 2025 to 2026

Pharmaceutical company

$30,000 Reported spend

6 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (206231), not by name.

Firms hired 1

HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP) $30,000 6 filings

Reported by year 2 years

2026 $0 2 filings
2025 $30,000 4 filings

Issues lobbied 1

Health Issues 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 2
SENATE 2

Recent filings 6 total

Q2Y

HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP)

2nd Quarter (Apr 1 - June 30) 2026 · posted Jul 14, 2026

View → Q1Y

HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP)

1st Quarter (Jan 1 - Mar 31) 2026 · posted Apr 13, 2026

View → Q4Y

HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP)

4th Quarter (Oct 1 - Dec 31) 2025 · posted Jan 20, 2026

View → Q3Y

HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP)

3rd Quarter (July 1 - Sep 30) 2025 · posted Oct 17, 2025

View → Q2

HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP)

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $10,000 income · posted Jul 16, 2025

View → Q1

HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP)

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $20,000 income · posted Apr 15, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.